QQQM: The Nasdaq 100 Is Having A Panic Attack And I Think This Pullback Should Be Bought

The article recommends buying Invesco NASDAQ 100 ETF (QQQM) after its 7.07% October decline, arguing that pricing reflects indiscriminate selling over CapEx concerns. Its top holdings trade at an earnings-weighted 15.7x next year's earnings, with double-digit EPS growth expected from the largest positions. Technology represents 59.2% of assets and the top 10 holdings 46.6%, increasing exposure to AI and CapEx cycles as well as volatility.

Analysis

The key question is not whether AI-related spending continues, but whether incremental spend converts into durable revenue and returns quickly enough to justify current earnings estimates. CapEx fears can be self-reinforcing in the near term: rising depreciation and weaker free-cash-flow conversion may pressure large buyers even while data-center, power, networking, and semiconductor suppliers see demand. That creates dispersion within a concentrated index, not a uniform “technology” trade.

Treat the cited earnings-weighted valuation cautiously. It can conceal expensive individual constituents, and forward earnings estimates may not yet reflect higher depreciation, execution delays, or weaker monetization. Over the next 1–3 months, earnings and company guidance on CapEx, utilization, and customer demand are more informative than the headline valuation. Over 6–18 months, the structural test is whether AI workloads produce enough incremental revenue to sustain returns on the enlarged asset base.

The contrarian risk is that indiscriminate selling has not fully priced the concentration: a few large holdings’ estimate revisions can dominate fund performance. Conversely, if spending remains firm, CapEx concerns may be overstated for suppliers and the selloff could offer an entry. The thesis weakens if major constituents cut expected AI-related revenue or spending plans, or if free-cash-flow conversion deteriorates without evidence of monetization. No company-level estimates or valuation methodology are supplied, so conviction should remain conditional.

Key Decisions for Investors

• Avoid treating the October decline alone as a buy signal. For a tactical long, scale into QQQM only after price stabilization or evidence from constituent earnings that revenue growth is keeping pace with CapEx; this reduces the risk of buying ahead of further estimate cuts.
• For investors seeking the growth exposure with less single-name concentration, consider pairing a smaller QQQM position with an equal-weight Nasdaq-100 exposure. The hedge may lag in a mega-cap-led rebound, but should reduce reliance on a handful of holdings.
• Use the next 1–3 months of earnings and guidance as the catalyst window: monitor AI-related revenue, CapEx plans, utilization, depreciation, and free-cash-flow conversion. Stronger monetization alongside sustained spending supports the long; rising spend with weaker conversion argues for reducing exposure.
• Falsification: broad downward revisions to large constituents’ forward earnings, cancellations or material deferrals of planned data-center investment, or persistent deterioration in cash generation without corresponding revenue acceleration. Verify the article’s valuation calculation and the underlying earnings-estimate dates before sizing a position.